M6A deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region
Ontology highlight
ABSTRACT: The N6-methyladenosine (m6A) RNA modification serves crucial functions in RNA metabolism; however, the molecular mechanisms underlying the regulation of m6A are not well understood. Here, we establish arginine methylation of METTL14, a component of the m6A methyltransferase complex, as a novel pathway that controls m6A-deposition in mammalian cells. Specifically, protein arginine methyltransferase 1 (PRMT1) interacts with, and methylates the intrinsically disordered C-terminus of METTL14, which promotes its interaction with RNA substrates, enhances its RNA methylation activity, and is crucial for its interaction with RNA polymerase II (RNAPII). Mouse embryonic stem cells (mESCs) expressing arginine methylation-deficient METTL14 exhibit significantly reduced global m6A levels. Transcriptome
SUBMITTER: Dr. Zhihao Wang
PROVIDER: S-SCDT-EMBOJ-2020-106309 | biostudies-other |
REPOSITORIES: biostudies-other
ACCESS DATA